BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37642393)

  • 1. Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review.
    Baudouin R; Hans S; Lisan Q; Morin B; Adimi Y; Martin J; Lechien JR; Tartour E; Badoual C
    Laryngoscope; 2024 Apr; 134(4):1507-1516. PubMed ID: 37642393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Atipas K; Laokulrath N; Petsuksiri J; Ratanaprasert N; Pongsapich W
    Curr Oncol; 2023 Jan; 30(2):1450-1460. PubMed ID: 36826072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
    van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
    Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Liu X; Liu P; Chernock RD; Lang Kuhs KA; Lewis JS; Li H; Gay HA; Thorstad WL; Wang X
    Int J Cancer; 2022 Feb; 150(3):521-531. PubMed ID: 34655477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
    Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
    J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of PD-L1
    Solomon B; Young RJ; Bressel M; Urban D; Hendry S; Thai A; Angel C; Haddad A; Kowanetz M; Fua T; Corry J; Fox S; Rischin D
    Cancer Immunol Res; 2018 Mar; 6(3):295-304. PubMed ID: 29378694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus, oropharyngeal cancer, and the latest vaccine: considerations for oral healthcare providers.
    Watt M; Li E; Closmann J; Chang O
    Gen Dent; 2024; 72(3):74-77. PubMed ID: 38640011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
    Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
    J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma.
    Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M
    J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature.
    Saber CN; Grønhøj Larsen C; Dalianis T; von Buchwald C
    Oral Oncol; 2016 Jul; 58():8-13. PubMed ID: 27311396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
    Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
    Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
    Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
    Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
    Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.